Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 59 | 2023 | 2303 | 7.360 |
Why?
|
| Homosexuality, Male | 26 | 2023 | 458 | 4.510 |
Why?
|
| Prisoners | 14 | 2023 | 83 | 4.150 |
Why?
|
| Anti-HIV Agents | 10 | 2023 | 420 | 3.120 |
Why?
|
| Sexual Behavior | 21 | 2022 | 609 | 3.020 |
Why?
|
| Sexually Transmitted Diseases | 11 | 2022 | 164 | 2.940 |
Why?
|
| Substance-Related Disorders | 9 | 2023 | 730 | 2.690 |
Why?
|
| Bisexuality | 9 | 2018 | 208 | 2.090 |
Why?
|
| Continuity of Patient Care | 6 | 2022 | 94 | 2.080 |
Why?
|
| Sexual Partners | 13 | 2022 | 314 | 1.900 |
Why?
|
| Prisons | 11 | 2020 | 49 | 1.650 |
Why?
|
| Los Angeles | 24 | 2022 | 380 | 1.600 |
Why?
|
| Risk-Taking | 12 | 2022 | 451 | 1.430 |
Why?
|
| Male | 61 | 2023 | 20025 | 1.390 |
Why?
|
| Condoms | 9 | 2018 | 135 | 1.340 |
Why?
|
| Humans | 80 | 2023 | 37093 | 1.310 |
Why?
|
| Unsafe Sex | 7 | 2020 | 161 | 1.230 |
Why?
|
| Adult | 44 | 2023 | 11712 | 1.090 |
Why?
|
| United States | 22 | 2023 | 4223 | 0.970 |
Why?
|
| Female | 40 | 2022 | 20969 | 0.930 |
Why?
|
| Siblings | 1 | 2023 | 18 | 0.920 |
Why?
|
| Central Nervous System Stimulants | 2 | 2022 | 174 | 0.880 |
Why?
|
| Peer Group | 3 | 2020 | 156 | 0.880 |
Why?
|
| Safe Sex | 5 | 2018 | 76 | 0.870 |
Why?
|
| Criminals | 3 | 2020 | 15 | 0.870 |
Why?
|
| Income Tax | 1 | 2022 | 1 | 0.860 |
Why?
|
| Psychiatry | 1 | 2022 | 27 | 0.840 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 864 | 0.770 |
Why?
|
| Cannabis | 1 | 2023 | 79 | 0.760 |
Why?
|
| HIV Seropositivity | 4 | 2014 | 190 | 0.760 |
Why?
|
| Middle Aged | 28 | 2022 | 10129 | 0.750 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2020 | 10 | 0.740 |
Why?
|
| Patient Participation | 1 | 2020 | 75 | 0.710 |
Why?
|
| Transsexualism | 2 | 2010 | 19 | 0.710 |
Why?
|
| Risk Reduction Behavior | 3 | 2022 | 127 | 0.700 |
Why?
|
| Patient Selection | 1 | 2020 | 164 | 0.680 |
Why?
|
| Trust | 1 | 2020 | 133 | 0.670 |
Why?
|
| Heterosexuality | 2 | 2011 | 88 | 0.640 |
Why?
|
| Minority Groups | 2 | 2020 | 596 | 0.590 |
Why?
|
| Young Adult | 14 | 2022 | 4268 | 0.560 |
Why?
|
| Behavior Therapy | 2 | 2018 | 167 | 0.550 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 404 | 0.520 |
Why?
|
| Crime | 2 | 2020 | 26 | 0.520 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 276 | 0.490 |
Why?
|
| HIV Seroprevalence | 3 | 2004 | 14 | 0.480 |
Why?
|
| Social Identification | 2 | 2016 | 58 | 0.480 |
Why?
|
| Adolescent | 15 | 2022 | 5363 | 0.440 |
Why?
|
| HIV | 4 | 2022 | 98 | 0.440 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 169 | 0.430 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 385 | 0.430 |
Why?
|
| Prejudice | 2 | 2009 | 110 | 0.390 |
Why?
|
| Income | 3 | 2022 | 140 | 0.380 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 560 | 0.380 |
Why?
|
| California | 5 | 2022 | 476 | 0.370 |
Why?
|
| Gender Identity | 3 | 2021 | 103 | 0.360 |
Why?
|
| Anti-Retroviral Agents | 2 | 2022 | 147 | 0.360 |
Why?
|
| Terminology as Topic | 1 | 2010 | 34 | 0.360 |
Why?
|
| Prevalence | 9 | 2017 | 1455 | 0.350 |
Why?
|
| Preventive Health Services | 1 | 2009 | 64 | 0.330 |
Why?
|
| Health Status Disparities | 3 | 2012 | 642 | 0.330 |
Why?
|
| Aged | 9 | 2023 | 6741 | 0.320 |
Why?
|
| Truth Disclosure | 2 | 2012 | 26 | 0.300 |
Why?
|
| Health Surveys | 2 | 2011 | 373 | 0.300 |
Why?
|
| Self Concept | 1 | 2008 | 154 | 0.300 |
Why?
|
| Logistic Models | 5 | 2020 | 923 | 0.290 |
Why?
|
| Research | 1 | 2008 | 163 | 0.280 |
Why?
|
| Risk Factors | 11 | 2018 | 3562 | 0.280 |
Why?
|
| Age Factors | 4 | 2018 | 1033 | 0.260 |
Why?
|
| Attitude | 1 | 2006 | 104 | 0.260 |
Why?
|
| Allostasis | 2 | 2017 | 12 | 0.250 |
Why?
|
| Mass Screening | 4 | 2020 | 462 | 0.250 |
Why?
|
| Health Promotion | 2 | 2022 | 653 | 0.240 |
Why?
|
| Criminal Law | 2 | 2021 | 26 | 0.240 |
Why?
|
| Ambulatory Care Facilities | 1 | 2004 | 61 | 0.240 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 494 | 0.230 |
Why?
|
| Health Expenditures | 1 | 2023 | 32 | 0.220 |
Why?
|
| Beauty Culture | 1 | 2022 | 2 | 0.220 |
Why?
|
| Incidence | 3 | 2022 | 922 | 0.220 |
Why?
|
| Feasibility Studies | 1 | 2023 | 208 | 0.220 |
Why?
|
| Focus Groups | 3 | 2018 | 348 | 0.210 |
Why?
|
| Methamphetamine | 2 | 2022 | 159 | 0.210 |
Why?
|
| Interviews as Topic | 2 | 2017 | 381 | 0.210 |
Why?
|
| Emigration and Immigration | 1 | 2002 | 82 | 0.210 |
Why?
|
| Medicare | 1 | 2023 | 195 | 0.200 |
Why?
|
| Social Support | 4 | 2020 | 394 | 0.200 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 64 | 0.200 |
Why?
|
| Mental Health | 2 | 2022 | 303 | 0.190 |
Why?
|
| Medicaid | 1 | 2022 | 109 | 0.190 |
Why?
|
| Qualitative Research | 2 | 2015 | 446 | 0.190 |
Why?
|
| RNA, Viral | 4 | 2018 | 301 | 0.180 |
Why?
|
| Sexuality | 2 | 2018 | 52 | 0.180 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 29 | 0.170 |
Why?
|
| Guideline Adherence | 2 | 2017 | 84 | 0.170 |
Why?
|
| HIV-1 | 4 | 2014 | 706 | 0.160 |
Why?
|
| Coitus | 2 | 2016 | 13 | 0.160 |
Why?
|
| Case Management | 1 | 2018 | 20 | 0.160 |
Why?
|
| Mortality | 2 | 2017 | 145 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2019 | 212 | 0.150 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 935 | 0.150 |
Why?
|
| Medication Adherence | 1 | 2020 | 179 | 0.150 |
Why?
|
| Personal Autonomy | 1 | 2017 | 18 | 0.150 |
Why?
|
| Residence Characteristics | 1 | 2020 | 322 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 56 | 0.150 |
Why?
|
| Disease Management | 1 | 2017 | 61 | 0.150 |
Why?
|
| Chicago | 4 | 2020 | 30 | 0.150 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 146 | 0.150 |
Why?
|
| Illinois | 3 | 2022 | 9 | 0.150 |
Why?
|
| Sex Factors | 2 | 2011 | 898 | 0.150 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 1067 | 0.140 |
Why?
|
| Religion | 1 | 2017 | 87 | 0.140 |
Why?
|
| Unemployment | 1 | 2016 | 23 | 0.140 |
Why?
|
| Community Health Services | 1 | 2017 | 185 | 0.130 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 48 | 0.130 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 2721 | 0.130 |
Why?
|
| Self Efficacy | 1 | 2016 | 184 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 974 | 0.120 |
Why?
|
| Counseling | 2 | 2018 | 116 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 205 | 0.120 |
Why?
|
| Time Factors | 4 | 2017 | 1742 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2015 | 325 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2013 | 339 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 664 | 0.100 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 22 | 0.090 |
Why?
|
| Hierarchy, Social | 1 | 2010 | 9 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 56 | 0.090 |
Why?
|
| Stress, Psychological | 2 | 2012 | 583 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 58 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2010 | 155 | 0.090 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2009 | 7 | 0.080 |
Why?
|
| History, 17th Century | 1 | 2009 | 5 | 0.080 |
Why?
|
| Viral Load | 3 | 2022 | 312 | 0.080 |
Why?
|
| History, 18th Century | 1 | 2009 | 6 | 0.080 |
Why?
|
| Contact Tracing | 1 | 2009 | 19 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2009 | 24 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2009 | 53 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 2379 | 0.080 |
Why?
|
| Culture | 1 | 2010 | 173 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2012 | 309 | 0.080 |
Why?
|
| Demography | 1 | 2009 | 175 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2009 | 117 | 0.080 |
Why?
|
| Urban Population | 2 | 2016 | 333 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2009 | 117 | 0.080 |
Why?
|
| Philadelphia | 2 | 2018 | 15 | 0.080 |
Why?
|
| Community Networks | 1 | 2009 | 108 | 0.080 |
Why?
|
| Cultural Competency | 1 | 2009 | 131 | 0.080 |
Why?
|
| Health Behavior | 1 | 2012 | 537 | 0.080 |
Why?
|
| Decision Making | 1 | 2009 | 203 | 0.070 |
Why?
|
| HIV Antibodies | 2 | 2004 | 30 | 0.070 |
Why?
|
| Age Distribution | 2 | 2003 | 225 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2020 | 1492 | 0.060 |
Why?
|
| Anonymous Testing | 1 | 2004 | 1 | 0.060 |
Why?
|
| Motivation | 1 | 2008 | 436 | 0.060 |
Why?
|
| Washington | 1 | 2004 | 31 | 0.060 |
Why?
|
| Southwestern United States | 1 | 2004 | 40 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2023 | 57 | 0.060 |
Why?
|
| Marital Status | 1 | 2003 | 40 | 0.060 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2004 | 121 | 0.050 |
Why?
|
| Depression | 2 | 2023 | 712 | 0.050 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 1999 | 72 | 0.050 |
Why?
|
| Texas | 1 | 2022 | 324 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2003 | 534 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1999 | 159 | 0.050 |
Why?
|
| Forecasting | 1 | 2020 | 128 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 1997 | 236 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1999 | 11 | 0.040 |
Why?
|
| Water Pollution | 1 | 1999 | 12 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1997 | 103 | 0.040 |
Why?
|
| Swimming | 1 | 1999 | 38 | 0.040 |
Why?
|
| Water Microbiology | 1 | 1999 | 76 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 275 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2019 | 180 | 0.040 |
Why?
|
| Pregnancy | 3 | 1999 | 1549 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 1378 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 197 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 562 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2014 | 262 | 0.040 |
Why?
|
| Cocaine | 1 | 2019 | 232 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 859 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 156 | 0.030 |
Why?
|
| Child | 1 | 2004 | 3131 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 441 | 0.030 |
Why?
|
| Intention | 1 | 2016 | 94 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 59 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1369 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 623 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 739 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 9 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 465 | 0.030 |
Why?
|
| Immunoassay | 1 | 2014 | 61 | 0.030 |
Why?
|
| Emotions | 1 | 2016 | 220 | 0.030 |
Why?
|
| Urban Health | 1 | 2013 | 95 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 144 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1130 | 0.030 |
Why?
|
| Behavior | 1 | 2010 | 32 | 0.020 |
Why?
|
| Alcoholism | 1 | 2013 | 240 | 0.020 |
Why?
|
| Carrier State | 1 | 2010 | 29 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 2001 | 10 | 0.020 |
Why?
|
| San Francisco | 1 | 2010 | 32 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 247 | 0.020 |
Why?
|
| beta 2-Microglobulin | 2 | 1999 | 10 | 0.020 |
Why?
|
| Neopterin | 2 | 1999 | 13 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 661 | 0.020 |
Why?
|
| Health Policy | 1 | 2009 | 165 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1997 | 88 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 1999 | 259 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1999 | 356 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2003 | 215 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 313 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2001 | 26 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 108 | 0.010 |
Why?
|
| Oceans and Seas | 1 | 1999 | 15 | 0.010 |
Why?
|
| Sewage | 1 | 1999 | 19 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1999 | 30 | 0.010 |
Why?
|
| Enterobacteriaceae | 1 | 1999 | 28 | 0.010 |
Why?
|
| Leisure Activities | 1 | 1999 | 33 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1997 | 57 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1997 | 121 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 189 | 0.010 |
Why?
|
| Postpartum Period | 1 | 1997 | 66 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1997 | 894 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 689 | 0.010 |
Why?
|
| Infant | 1 | 1997 | 1046 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1997 | 2026 | 0.010 |
Why?
|